Report Detail

Pharma & Healthcare Global Large Volume Parenterals (LVP) Market Insights, Forecast to 2025

  • RnM3199513
  • |
  • 27 March, 2019
  • |
  • Global
  • |
  • 113 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Large Volume Parenterals (LVP) Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Large Volume Parenterals (LVP) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Large Volume Parenterals (LVP) Market Size Growth Rate by Product
      • 1.4.2 Fluid Balance Injections
      • 1.4.3 Therapeutic Injections
      • 1.4.4 Nutritious Injections
    • 1.5 Market by End User
      • 1.5.1 Global Large Volume Parenterals (LVP) Market Size Growth Rate by End User
      • 1.5.2 Intravenous
      • 1.5.3 Intramuscular
      • 1.5.4 Subcutaneous
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Large Volume Parenterals (LVP) Market Size
      • 2.1.1 Global Large Volume Parenterals (LVP) Revenue 2014-2025
      • 2.1.2 Global Large Volume Parenterals (LVP) Sales 2014-2025
    • 2.2 Large Volume Parenterals (LVP) Growth Rate by Regions
      • 2.2.1 Global Large Volume Parenterals (LVP) Sales by Regions
      • 2.2.2 Global Large Volume Parenterals (LVP) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Large Volume Parenterals (LVP) Sales by Manufacturers
      • 3.1.1 Large Volume Parenterals (LVP) Sales by Manufacturers
      • 3.1.2 Large Volume Parenterals (LVP) Sales Market Share by Manufacturers
      • 3.1.3 Global Large Volume Parenterals (LVP) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Large Volume Parenterals (LVP) Revenue by Manufacturers
      • 3.2.1 Large Volume Parenterals (LVP) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Large Volume Parenterals (LVP) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Large Volume Parenterals (LVP) Price by Manufacturers
    • 3.4 Large Volume Parenterals (LVP) Manufacturing Base Distribution, Product Types
      • 3.4.1 Large Volume Parenterals (LVP) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Large Volume Parenterals (LVP) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Large Volume Parenterals (LVP) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Large Volume Parenterals (LVP) Sales by Product
    • 4.2 Global Large Volume Parenterals (LVP) Revenue by Product
    • 4.3 Large Volume Parenterals (LVP) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Large Volume Parenterals (LVP) Breakdown Data by End User

    6 North America

    • 6.1 North America Large Volume Parenterals (LVP) by Countries
      • 6.1.1 North America Large Volume Parenterals (LVP) Sales by Countries
      • 6.1.2 North America Large Volume Parenterals (LVP) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Large Volume Parenterals (LVP) by Product
    • 6.3 North America Large Volume Parenterals (LVP) by End User

    7 Europe

    • 7.1 Europe Large Volume Parenterals (LVP) by Countries
      • 7.1.1 Europe Large Volume Parenterals (LVP) Sales by Countries
      • 7.1.2 Europe Large Volume Parenterals (LVP) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Large Volume Parenterals (LVP) by Product
    • 7.3 Europe Large Volume Parenterals (LVP) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Large Volume Parenterals (LVP) by Countries
      • 8.1.1 Asia Pacific Large Volume Parenterals (LVP) Sales by Countries
      • 8.1.2 Asia Pacific Large Volume Parenterals (LVP) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Large Volume Parenterals (LVP) by Product
    • 8.3 Asia Pacific Large Volume Parenterals (LVP) by End User

    9 Central & South America

    • 9.1 Central & South America Large Volume Parenterals (LVP) by Countries
      • 9.1.1 Central & South America Large Volume Parenterals (LVP) Sales by Countries
      • 9.1.2 Central & South America Large Volume Parenterals (LVP) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Large Volume Parenterals (LVP) by Product
    • 9.3 Central & South America Large Volume Parenterals (LVP) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Large Volume Parenterals (LVP) by Countries
      • 10.1.1 Middle East and Africa Large Volume Parenterals (LVP) Sales by Countries
      • 10.1.2 Middle East and Africa Large Volume Parenterals (LVP) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Large Volume Parenterals (LVP) by Product
    • 10.3 Middle East and Africa Large Volume Parenterals (LVP) by End User

    11 Company Profiles

    • 11.1 Ostuka Pharmaceutical (Japan)
      • 11.1.1 Ostuka Pharmaceutical (Japan) Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Ostuka Pharmaceutical (Japan) Large Volume Parenterals (LVP) Products Offered
      • 11.1.5 Ostuka Pharmaceutical (Japan) Recent Development
    • 11.2 Teva Pharmaceutical Industries Limited (Israel)
      • 11.2.1 Teva Pharmaceutical Industries Limited (Israel) Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Teva Pharmaceutical Industries Limited (Israel) Large Volume Parenterals (LVP) Products Offered
      • 11.2.5 Teva Pharmaceutical Industries Limited (Israel) Recent Development
    • 11.3 Kelun Pharma (China)
      • 11.3.1 Kelun Pharma (China) Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Kelun Pharma (China) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Kelun Pharma (China) Large Volume Parenterals (LVP) Products Offered
      • 11.3.5 Kelun Pharma (China) Recent Development
    • 11.4 Cook Pharmica LLC (Catalent) (US)
      • 11.4.1 Cook Pharmica LLC (Catalent) (US) Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Cook Pharmica LLC (Catalent) (US) Large Volume Parenterals (LVP) Products Offered
      • 11.4.5 Cook Pharmica LLC (Catalent) (US) Recent Development
    • 11.5 Patheon Inc. (Netherlands)
      • 11.5.1 Patheon Inc. (Netherlands) Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Patheon Inc. (Netherlands) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Patheon Inc. (Netherlands) Large Volume Parenterals (LVP) Products Offered
      • 11.5.5 Patheon Inc. (Netherlands) Recent Development
    • 11.6 BAG Healthcare (Germany)
      • 11.6.1 BAG Healthcare (Germany) Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 BAG Healthcare (Germany) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 BAG Healthcare (Germany) Large Volume Parenterals (LVP) Products Offered
      • 11.6.5 BAG Healthcare (Germany) Recent Development
    • 11.7 Southwest Pharmaceutical Co. Ltd. (China)
      • 11.7.1 Southwest Pharmaceutical Co. Ltd. (China) Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Southwest Pharmaceutical Co. Ltd. (China) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Southwest Pharmaceutical Co. Ltd. (China) Large Volume Parenterals (LVP) Products Offered
      • 11.7.5 Southwest Pharmaceutical Co. Ltd. (China) Recent Development
    • 11.8 Beximco Pharma (Bangladesh)
      • 11.8.1 Beximco Pharma (Bangladesh) Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Beximco Pharma (Bangladesh) Large Volume Parenterals (LVP) Products Offered
      • 11.8.5 Beximco Pharma (Bangladesh) Recent Development
    • 11.9 Baxter Healthcare Corporation (US)
      • 11.9.1 Baxter Healthcare Corporation (US) Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Baxter Healthcare Corporation (US) Large Volume Parenterals (LVP) Products Offered
      • 11.9.5 Baxter Healthcare Corporation (US) Recent Development

    12 Future Forecast

    • 12.1 Large Volume Parenterals (LVP) Market Forecast by Regions
      • 12.1.1 Global Large Volume Parenterals (LVP) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Large Volume Parenterals (LVP) Revenue Forecast by Regions 2019-2025
    • 12.2 Large Volume Parenterals (LVP) Market Forecast by Product
      • 12.2.1 Global Large Volume Parenterals (LVP) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Large Volume Parenterals (LVP) Revenue Forecast by Product 2019-2025
    • 12.3 Large Volume Parenterals (LVP) Market Forecast by End User
    • 12.4 North America Large Volume Parenterals (LVP) Forecast
    • 12.5 Europe Large Volume Parenterals (LVP) Forecast
    • 12.6 Asia Pacific Large Volume Parenterals (LVP) Forecast
    • 12.7 Central & South America Large Volume Parenterals (LVP) Forecast
    • 12.8 Middle East and Africa Large Volume Parenterals (LVP) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Large Volume Parenterals (LVP) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Large Volume Parenterals (LVP) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Large Volume Parenterals (LVP) market based on company, product type, end user and key regions.

      This report studies the global market size of Large Volume Parenterals (LVP) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Large Volume Parenterals (LVP) in these regions.
      This research report categorizes the global Large Volume Parenterals (LVP) market by top players/brands, region, type and end user. This report also studies the global Large Volume Parenterals (LVP) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Ostuka Pharmaceutical (Japan)
      Teva Pharmaceutical Industries Limited (Israel)
      Kelun Pharma (China)
      Cook Pharmica LLC (Catalent) (US)
      Patheon Inc. (Netherlands)
      BAG Healthcare (Germany)
      Southwest Pharmaceutical Co. Ltd. (China)
      Beximco Pharma (Bangladesh)
      Baxter Healthcare Corporation (US)

      Market size by Product
      Fluid Balance Injections
      Therapeutic Injections
      Nutritious Injections
      Market size by End User
      Intravenous
      Intramuscular
      Subcutaneous
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Large Volume Parenterals (LVP) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Large Volume Parenterals (LVP) market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Large Volume Parenterals (LVP) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Large Volume Parenterals (LVP) submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Large Volume Parenterals (LVP) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Large Volume Parenterals (LVP) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Large Volume Parenterals (LVP) . Industry analysis & Market Report on Large Volume Parenterals (LVP) is a syndicated market report, published as Global Large Volume Parenterals (LVP) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Large Volume Parenterals (LVP) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,135.60
      4,703.40
      6,271.20
      3,536.31
      5,304.46
      7,072.62
      421,621.20
      632,431.80
      843,242.40
      279,653.01
      419,479.52
      559,306.02
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report